Aguettant diversifies into in vitro diagnostics. Aware that therapy and diagnosis are closely linked, we mobilize our expertise within our two subsidiaries in favor of solutions dedicated to the biological monitoring of biotherapies as well as the development of medical countermeasures against CBRN (Chemical, Biological, Radiological, and Nuclear) risks.
to find out more,
visit the sites of our diagnostic entities :
Aguettant Diagnostics is an integrated company dedicated to the design, development, manufacturing and registration of diagnostic solutions.
See the website
Promise Proteomics is a pioneering MedTech company and expert in the development of quantification methods based on mass spectrometry and in the bioproduction of proteins labeled with stable isotopes (SIL). Capitalizing on its unique know-how, Promise Proteomics puts its skills at the service of healthcare professionals through its mAbXmise kits.
See the website